食品伙伴网讯   据欧盟食品安全局（EFSA）消息，2018年7月23日，欧盟就蛋膜水解产物（egg membrane hydrolysate）作为新型食品的安全性发布意见。

 

    应欧盟委员会的要求，欧盟膳食、营养和过敏症科学小组（NDA）按照 法规（EU）2015/2283提供关于蛋膜水解产物作为新型食品安全性的科学意见。蛋膜水解产物是一种水溶性的卵膜水解物，是通过对蛋壳薄层进行碱性处理而得到的。它的主要成分是弹性蛋白、胶原蛋白和糖胺聚糖。经过评估，专家小组得出结论，蛋膜水解产物作为新型食品在拟议的使用限量下是安全的，剂量为450mg/天，目标人群是普通成年人。

 

    部分原文报道如下：

 

    Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies （NDA） was asked to deliver a scientific opinion on egg membrane hydrolysate as a novel food （NF） pursuant to Regulation （EU） 2015/2283. The NF is a water‐soluble hydrolysate of egg membrane, produced by alkaline treatment of the thin layer lining the shells of chicken eggs. The main constituents of the NF are elastin, collagen and glycosaminoglycans. The information provided on the production process, batch‐to‐batch variability, composition and specifications of the NF is sufficient and does not raise safety concerns. The NF is proposed to be used as a food supplement for adults, at a maximum daily amount of 450 mg. The consumption of the NF is not nutritionally disadvantageous. One human study, which was not designed for safety but included a number of endpoints pertaining to safety, did not raise safety concerns. The Panel considers that taking into account the information provided and considering the nature, the source and the production process of the NF, there are no safety concerns for the NF at the proposed conditions of use. The Panel concludes that the NF, egg membrane hydrolysate, is safe as a food supplement at a dose of 450 mg/day. The target population for the NF is the general adult population.